Certain clinicopathological characteristics of EML4-ALK-positive NSCLCs, including a young age at onset, lack of a smoking history and adenocarcinoma histology (8), are also observed in patients with NSCLC that harbours EGFR mutations (3). This evidence concerns the gene EML4 and adenocarcinoma.